Skip to main content
Top

Lung

Issue 4/2007

Content (6 Articles)

REVIEW

Alpha-1-Antitrypsin Deficiency: Current Concepts

Alan T. Mulgrew, Clifford C. Taggart, N. Gerry McElvaney

State of the Art Review

The Impact of Housestaff Fatigue on Occupational and Patient Safety

Scot A. Mountain, Bradley S. Quon, Peter Dodek, Robert Sharpe, Najib T. Ayas

Book Review

Interstitial Lung Disease in Systemic Sclerosis

Predrag Ostojic, Marco Matucci Cerinic, Richard Silver, Kristin Highland, Nemanja Damjanov

Do the Benefits Gained Using a Short-Term Pulmonary Rehabilitation Program Remain in COPD Patients After Participation?

Hale Karapolat, Alev Atasever, Funda Atamaz, Yeşim Kirazlı, Funda Elmas, Ertürk Erdinç

Short-Term Cigarette Smoke Exposure Predisposes the Lung to Secondary Injury

Tapan M. Bhavsar, Joseph M. Cerreta, Jerome O. Cantor

Sleep Apnea Syndrome in a Referral Population in Greece: Influence of Social Factors

N. Charokopos, M. Leotsinidis, M. Tsiamita, K. Karkoulias, K. Spiropoulos

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine